RadNet, Inc. Increase (Decrease) in Other Current Assets
RadNet, Inc. (RDNT) reported Increase (Decrease) in Other Current Assets of $1.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-10
- RadNet, Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$5.04M.
- RadNet, Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $6.17M, a 14.35% decline year-over-year.
- RadNet, Inc. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$186.00K, a 100.50% decline year-over-year.
- RadNet, Inc. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $20.29M, a 3925.40% increase year-over-year.
- RadNet, Inc. increase (decrease) in other current assets for fiscal 2025 was -$2.28M, a 106.95% decline from fiscal 2024.
- RadNet, Inc. increase (decrease) in other current assets for fiscal 2024 was $32.79M, a 288.46% increase from fiscal 2023.
- RadNet, Inc. increase (decrease) in other current assets for fiscal 2023 was $8.44M, a 153.71% increase from fiscal 2022.
- RadNet, Inc. increase (decrease) in other current assets for fiscal 2022 was $3.33M, a 78.91% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.13M 10-Q · filed 2026-08-10 | $945.00K derived: sum of 3 quarters · filed 2026-08-10 | $21.23M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $6.17M 10-Q · filed 2026-05-11 | $5.99M derived: sum of 2 quarters · filed 2026-05-11 | $26.27M derived: sum of 3 quarters · filed 2026-05-11 | -$3.31M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $20.10M derived: sum of 2 quarters · filed 2026-03-02 | -$9.48M derived: sum of 3 quarters · filed 2026-08-10 | -$2.28M 10-K · filed 2026-03-02 |
| 2025-09-30 | $20.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$9.30M derived: sum of 2 quarters · filed 2026-08-10 | -$2.09M 10-Q · filed 2025-11-10 | $35.44M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$29.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$22.38M 10-Q · filed 2026-08-10 | $15.15M derived: sum of 3 quarters · filed 2026-08-10 | $15.65M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $7.21M 10-Q · filed 2026-05-11 | $44.73M derived: sum of 2 quarters · filed 2026-05-11 | $45.24M derived: sum of 3 quarters · filed 2026-05-11 | $33.72M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $37.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $38.03M derived: sum of 2 quarters · filed 2026-03-02 | $26.51M derived: sum of 3 quarters · filed 2026-03-02 | $32.79M 10-K · filed 2026-03-02 |
| 2024-09-30 | $504.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$11.02M derived: sum of 2 quarters · filed 2025-11-10 | -$4.74M 10-Q · filed 2025-11-10 | $9.46M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$11.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$5.24M 10-Q · filed 2025-08-11 | $8.95M derived: sum of 3 quarters · filed 2026-03-02 | $7.90M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $6.28M 10-Q · filed 2025-05-12 | $20.47M derived: sum of 2 quarters · filed 2026-03-02 | $19.42M derived: sum of 3 quarters · filed 2026-03-02 | $13.03M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $13.14M derived: sum of 2 quarters · filed 2026-03-02 | $6.75M derived: sum of 3 quarters · filed 2026-03-02 | $8.44M 10-K · filed 2026-03-02 |
| 2023-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$7.45M derived: sum of 2 quarters · filed 2024-11-12 | -$5.75M 10-Q · filed 2024-11-12 | -$7.36M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$6.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$4.70M 10-Q · filed 2024-08-09 | -$6.31M derived: sum of 3 quarters · filed 2025-03-03 | -$2.08M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $1.69M 10-Q · filed 2024-05-10 | $84.00K derived: sum of 2 quarters · filed 2025-03-03 | $4.31M derived: sum of 3 quarters · filed 2025-03-03 | $953.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.62M derived: sum of 2 quarters · filed 2025-03-03 | -$738.00K derived: sum of 3 quarters · filed 2025-03-03 | $3.33M 10-K · filed 2025-03-03 |
| 2022-09-30 | $4.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $869.00K derived: sum of 2 quarters · filed 2023-11-09 | $4.93M 10-Q · filed 2023-11-09 | $24.07M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$3.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $709.00K 10-Q · filed 2023-08-09 | $19.84M derived: sum of 3 quarters · filed 2024-02-29 | $19.45M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $4.07M 10-Q · filed 2023-05-10 | $23.20M derived: sum of 2 quarters · filed 2024-02-29 | $22.80M derived: sum of 3 quarters · filed 2024-02-29 | $15.53M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $19.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $18.74M derived: sum of 2 quarters · filed 2024-02-29 | $11.47M derived: sum of 3 quarters · filed 2024-02-29 | $15.78M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$395.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$7.67M derived: sum of 2 quarters · filed 2022-11-09 | -$3.36M 10-Q · filed 2022-11-09 | $3.58M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$7.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.96M 10-Q · filed 2022-08-09 | $3.97M derived: sum of 3 quarters · filed 2023-03-01 | $333.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $4.31M 10-Q · filed 2022-05-10 | $11.24M derived: sum of 2 quarters · filed 2023-03-01 | $7.60M derived: sum of 3 quarters · filed 2023-03-01 | $2.88M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $6.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.30M derived: sum of 2 quarters · filed 2023-03-01 | -$1.42M derived: sum of 3 quarters · filed 2023-03-01 | -$6.59M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$8.36M derived: sum of 2 quarters · filed 2021-11-09 | -$13.52M 10-Q · filed 2021-11-09 | -$11.53M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$9.88M 10-Q · filed 2021-08-09 | -$7.90M derived: sum of 3 quarters · filed 2022-03-01 | -$2.00M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$5.16M 10-Q · filed 2021-05-10 | -$3.18M derived: sum of 2 quarters · filed 2022-03-01 | $2.72M derived: sum of 3 quarters · filed 2022-03-01 | -$2.79M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.89M derived: sum of 2 quarters · filed 2022-03-01 | $2.37M derived: sum of 3 quarters · filed 2022-03-01 | $3.56M 10-K · filed 2022-03-01 |
| 2019-09-30 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $385.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.57M 10-Q · filed 2020-11-09 | $5.14M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | -$5.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$4.33M 10-Q · filed 2020-08-10 | -$763.00K derived: sum of 3 quarters · filed 2021-03-16 | $4.35M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $1.18M 10-Q · filed 2020-05-11 | $4.75M derived: sum of 2 quarters · filed 2021-03-16 | $9.86M derived: sum of 3 quarters · filed 2021-03-16 | $11.44M derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $8.68M derived: sum of 2 quarters · filed 2021-03-16 | $10.25M derived: sum of 3 quarters · filed 2021-03-16 | $9.25M 10-K · filed 2021-03-16 |
| 2018-09-30 | $5.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $6.68M derived: sum of 2 quarters · filed 2019-11-12 | $5.68M 10-Q · filed 2019-11-12 | $7.20M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $568.00K 10-Q · filed 2019-08-09 | $2.09M derived: sum of 3 quarters · filed 2020-03-16 | $3.66M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | -$1.00M 10-Q · filed 2019-05-10 | $517.00K derived: sum of 2 quarters · filed 2020-03-16 | $2.09M derived: sum of 3 quarters · filed 2020-03-16 | $1.58M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $3.09M derived: sum of 2 quarters · filed 2020-03-16 | $2.58M derived: sum of 3 quarters · filed 2020-03-16 | -$1.46M 10-K · filed 2020-03-16 |
| 2017-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.06M derived: sum of 2 quarters · filed 2018-11-09 | -$2.98M 10-Q · filed 2018-11-09 | -$3.60M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | -$510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$4.55M 10-Q · filed 2018-08-09 | -$5.17M derived: sum of 3 quarters · filed 2019-03-18 | -$7.14M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | -$4.04M 10-Q · filed 2018-05-10 | -$4.66M derived: sum of 2 quarters · filed 2019-03-18 | -$6.63M derived: sum of 3 quarters · filed 2019-03-18 | -$9.79M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | -$618.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$2.58M derived: sum of 2 quarters · filed 2019-03-18 | -$5.75M derived: sum of 3 quarters · filed 2019-03-18 | -$11.04M 10-K · filed 2019-03-18 |
| 2016-09-30 | -$1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$5.13M derived: sum of 2 quarters · filed 2017-11-09 | -$10.42M 10-Q · filed 2017-11-09 | -$11.85M derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-06-30 | -$3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$8.45M 10-Q · filed 2017-08-09 | -$9.88M derived: sum of 3 quarters · filed 2018-03-19 | $2.69M derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-03-31 | -$5.29M 10-Q · filed 2017-05-10 | -$6.72M derived: sum of 2 quarters · filed 2018-03-19 | $5.85M derived: sum of 3 quarters · filed 2018-03-19 | $11.70M derived: sum of 4 quarters · filed 2018-03-19 |
| 2015-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $11.14M derived: sum of 2 quarters · filed 2018-03-19 | $16.98M derived: sum of 3 quarters · filed 2018-03-19 | $14.20M 10-K · filed 2018-03-19 |
| 2015-09-30 | $12.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $18.41M derived: sum of 2 quarters · filed 2016-11-09 | $15.63M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $5.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.06M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$2.79M 10-Q · filed 2016-05-10 | |||
| 2014-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $251.00K derived: sum of 2 quarters · filed 2015-11-09 | $4.75M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $2.88M 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $4.50M 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |